Imbalances in these neurotransmitters, whether they are too active or not active enough, have been linked to alcohol addiction
Benefits have also been shown in low back pain, autistic spectrum disorders and aphthous ulcers, although this is based on small numbers of clinical trials
Tirzepatide mimics both GLP-1 and GIP, providing a "double signal" to the brain and body
Moreover, a fluctuant increase in reported cases over time was observed, which may have resulted from the elevated numbers of approved drugs and optimized administration of GLP-1RAs in clinical practice
Firmicutes were significantly decreased whereas Bacteroidetes were significantly increased in the individuals post-RYGB
The goal is to increase the dose gradually until the highest tolerable dose (a dose that reaches the desired effect without unacceptable side effects) is reached